[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Cipher Pharmaceuticals Inc (CPH.TO)

Cipher Pharmaceuticals Inc (CPH.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])

Fundamentals

See More
  • Market Capitalization, $K 419,211
  • Shares Outstanding, K 25,391
  • Annual Sales, $ 50,451 K
  • Annual Income, $ 27,329 K
  • EBIT $ N/A
  • EBITDA $ N/A
  • 60-Month Beta 0.89
  • Price/Sales 6.13
  • Price/Cash Flow 10.31
  • Price/Book 2.29

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 3 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.30
  • Number of Estimates 1
  • High Estimate $0.30
  • Low Estimate $0.30
  • Prior Year $0.30
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.35 +2.08%
on 05/26/26
20.56 -18.82%
on 05/08/26
-1.41 (-7.79%)
since 04/29/26
3-Month
14.20 +17.54%
on 03/12/26
20.56 -18.82%
on 05/08/26
+1.68 (+11.19%)
since 02/27/26
52-Week
11.98 +39.32%
on 08/01/25
20.56 -18.82%
on 05/08/26
+4.23 (+33.95%)
since 05/28/25

Most Recent Stories

More News
Upcoming Meeting Dates - May 4, 2026

Toronto, Ontario--(Newsfile Corp. - May 4, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through...

DEFI.NE : 0.9400 (+3.30%)
ROOT.TO : 4.24 (+0.95%)
IMP.TO : 1.16 (+5.45%)
BYRG.CN : 0.2250 (+9.76%)
CPH.TO : 16.69 (+1.09%)
SRQ.VN : 0.075 (unch)
PTF.VN : 15.040 (unch)
CSG.VN : 0.080 (+14.29%)
RCK.VN : 0.940 (-1.05%)
SSE.VN : 0.135 (-3.57%)
EGLX.TO : 0.0600 (unch)
NTX.VN : 0.100 (+5.26%)
Cipher Pharmaceuticals Schedules Q1 2026 Earnings Release and Conference Call

MISSISSAUGA, ON , April 29, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Upcoming Meeting Dates - April 20, 2026

Toronto, Ontario--(Newsfile Corp. - April 20, 2026) - The following is a list of Upcoming Meeting Dates announced this week for Reporting Issuers in Canada. The data is supplied by Issuing Companies through...

SGN.VN : 0.350 (unch)
TXP.TO : 0.1350 (unch)
MAI.VN : 7.110 (+2.60%)
WVM.VN : 1.730 (+1.76%)
BRAG.TO : 2.42 (+4.31%)
BRM.VN : 3.140 (-0.95%)
BYRG.CN : 0.2250 (+9.76%)
CPH.TO : 16.69 (+1.09%)
GAME.VN : 1.800 (+5.88%)
RSM.VN : 0.310 (+1.64%)
ESM.TO : 0.2000 (unch)
IPT.VN : 0.360 (-5.26%)
Cipher Pharmaceuticals Schedules Q4 & Fiscal 2025 Earnings Release and Conference Call

MISSISSAUGA, ON , March 4, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Cipher Pharmaceuticals Announces Health Canada's Acceptance for Review of New Drug Submission for Natroba™ (Spinosad)

MISSISSAUGA, ON , Jan. 28, 2026 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that Health Canada has accepted for review Cipher's...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Cipher Pharmaceuticals Reports Third Quarter 2025 Results

(All figures are presented in U.S. Dollars)

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Cipher Pharmaceuticals Schedules Q3 2025 Earnings Release and Conference Call

MISSISSAUGA, ON , Oct. 29, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") today announced that it will release its financial results for...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Stocks in play: Cipher Pharmaceuticals Inc.

Has received a favourable award from an extensive and comprehensive arbitration proceeding, related ...

CPH.TO : 16.69 (+1.09%)
Cipher Pharmaceuticals Receives Successful Arbitration Award

MISSISSAUGA, ON , Oct. 14, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") has received a favourable award from an extensive and comprehensive...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)
Cipher Pharmaceuticals Announces the Passing of Director Mr. Harold Wolkin

MISSISSAUGA, ON , Aug. 26, 2025 /CNW/ - Cipher Pharmaceuticals Inc. (TSX: CPH) (OTCQX: CPHRF) (" Cipher " or the " Company ") announces with great sadness the passing of Harold...

CPH.TO : 16.69 (+1.09%)
CPHRF : 12.0000 (-0.95%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Cipher Pharmaceuticals Inc is a specialty pharmaceutical company with a diversified portfolio of commercial and early to late-stage products. The Company is building its business through product acquisitions, out-licensing, and in-licensing arrangements. Its products include Dermatology Products, Hospital...

See More

Key Turning Points

3rd Resistance Point 17.19
2nd Resistance Point 17.02
1st Resistance Point 16.85
Last Price 16.69
1st Support Level 16.51
2nd Support Level 16.34
3rd Support Level 16.17

See More

52-Week High 20.56
Fibonacci 61.8% 17.28
Last Price 16.69
Fibonacci 50% 16.27
Fibonacci 38.2% 15.26
52-Week Low 11.98

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.